NuraLogix releases AI longevity mirror for predictive health
AI-powered longevity mirror offers a 30-second scan that projects your health trajectory, helping you see and shape your…
AI has finger on pulse of healthcare advances
SONG CHEN/CHINA DAILY Song Jiayi, a 32-year-old white-collar worker in Beijing, usually goes to the gym after work.…
Breastfeeding linked to reduced maternal depression and anxiety up to ten years
Breastfeeding may lower mothers’ later life risks of depression and anxiety for up to 10 years after pregnancy,…
CrazyHunter Ransomware Attacking Healthcare Sector with Advanced Evasion Techniques
CrazyHunter ransomware has emerged as a critical and evolving threat that specifically targets healthcare organizations and sensitive medical…
Can This Healthcare Stock Keep Going After a Nearly 70% Surge?
Amneal Pharmaceuticals (AMRX) is trading at new 5-year highs with strong technical momentum.AMRX has gained 69% over the…
Clinic O / Takayuki Kuzushima and Associates
Courtesy of Takayuki Kuzushima and Associates + 24 Share Share Facebook Twitter Mail Pinterest Whatsapp Or https://www.archdaily.com/1037566/clinic-o-takayuki-kuzushima-and-associates Area…
Kate talks of ‘daunting’ cancer treatment on hospital visit with William
The Princess of Wales has said that “important things not in the job description” such as “kindness” matter…
A Therapy Tool for Memory Care Patients
I’ve seen several robots at the Consumer Electronics Show (CES), some cute and cuddly, others not so much.…
Five healthy habits for successfully aging in our 60s and 70s — and beyond
Even if someone doesn’t feel frail, the 60s and 70s are the ideal time to start working on…
They want better health care — so they’re turning to crypto startups
By his own admission, the company that Andrew Verbinnen cofounded is a vanity project — literally. It’s called…
Flu and RSV Cases Rise Across Greece, Health Officials Warn
Flu and RSV cases are rising across Greece, with children and vulnerable populations most affected, according to public…
AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)
Durham, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) — AB-1009 program advances to Phase 1/Phase 2; clinical trial initiated…